For Immediate Release
2019.02.22
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Sunao Manabe, Representative Director, President and COO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Koji Ogawa, Corporate Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
https://www.daiichisankyo.com
Daiichi Sankyo Appoints New Group Corporate Officers
TOKYO, Japan (February 22, 2019) - Daiichi Sankyo Company, Limited today announced the appointment of new Group corporate officers effective from April 1, 2019.
1. DAIICHI SANKYO CO., LTD.
Name | Current Responsibilities | New Responsibilities |
Katsumi Fujimoto |
Member of the Board | Member of the Board |
Toshiaki Tojo |
Member of the Board |
Member of the Board |
Junichi Koga |
Senior Executive Officer |
Senior Executive Officer |
Masahiko Ohtsuki |
Corporate Officer |
Executive Officer |
Junichi Fukute |
Corporate Officer |
Executive Officer |
Takeshi Hamaura |
Corporate Officer |
Executive Officer |
Shoji Hirashima |
Corporate Officer |
Executive Officer |
Ryoichi Watanabe | Corporate Officer Vice President of Internal Audit Dept. |
Corporate Officer |
Hironobu Furuta |
Corporate Officer | Corporate Officer Head of Corporate Affairs Div. |
Koji Ogawa |
Corporate Officer |
Corporate Officer |
Seiichiro Kumakura |
Vice President of Research Function, |
Corporate Officer |
Takashi Fukuoka |
Vice President of Venture Science |
Corporate Officer |
Hironobu Saito |
Vice President of Oncology Clinical |
Corporate Officer |
Wataru Takasaki |
Vice President of R&D Planning & |
Corporate Officer |
Tomoji Hashiba |
Vice President of Tohoku Branch, |
Corporate Officer |
Miyuki Arai |
Vice President of Safety and Risk |
Corporate Officer |
◇Glenn Gormley (current Senior Executive Officer) will continue to serve as Executive Chairman of the Board of Daiichi Sankyo, Inc.
◇Koichi Akahane, Yoshihiro Aoyagi, Yuichi Kubo and Kohei Wada (current Executive Officer) will be appointed Corporate Advisor as of April 1st, 2019.
◇Kenji Katsumi (current Corporate Officer) will be appointed the President of Daiichi Sankyo Business Associe Co., Ltd. as of April 1st, 2019.
◇Kentaro Murakawa (current Corporate Officer) will be appointed the President of Daiichi Sankyo Espha Co., Ltd. as of April 1st, 2019.
◇Hirosumi Izawa (current Corporate Officer) will be appointed the President of Daiichi Sankyo Propharma Co., Ltd. as of April 1st, 2019.
2. DAIICHI SANKYO ESPHA CO., LTD.
Name | Current Responsibilities | New Responsibilities |
Kentaro Murakawa |
Corporate Officer | President |
Ichiro Ishizuka |
Member of the Board |
Executive Vice President |
Hiroto Yoshiwaka | President | Member of the Board |
Takeshi Shinseki |
Member of the Board |
Member of the Board |
Kosuke Natori | Vice President of Corporate Strategy Dept. |
Member of the Board |
3. DAIICHI SANKYO HEALTHCARE CO., LTD.
Name | Current Responsibilities | New Responsibilities |
Yoshiki Nishii | President | Chairman |
Katsuhiko Yoshida |
Member of the Board | President |
Yasuhiro Kawanaka |
Member of the Board | Member of the Board |
Masatoshi Yamamoto |
Corporate Officer |
Member of the Board |
Tomohiko Yamaguchi |
Corporate Officer |
Member of the Board |
Attachments
- Original document
- Permalink
Disclaimer
Daiichi Sankyo Co. Ltd. published this content on 22 February 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 22 February 2019 01:24:03 UTC